Experimental drug NU-9 halts Alzheimer’s disease in animal model before symptoms begin – BioNews Central The experimental drug NU-9 significantly reduced toxic amyloid beta oligomers and related neuronal damage in a mouse model of Alzheimer's disease, demonstrating potential as an early therapeutic intervention. ...

The #ExperimentalDrug NU-9 significantly reduced toxic #AmyloidBeta oligomers and related #NeuronalDamage in a mouse model of #AlzheimersDisease, demonstrating potential as an early #TherapeuticIntervention. 

This recent study shows that NRC activates the #Mitochondrial #UnfoldedProteinResponse and restores #Fundc1-driven #Mitophagy, counteracting #NeuronalDamage and highlighting a novel therapeutic strategy for alcohol-related disorders. #medsky

#OpenAccess: www.sciencedirect.com/science/arti...

Injury-specific #proteomic signatures in single & repetitive mild #TBI show that while a single TBI promotes #neuroprotection & repair, repetitive TBI worsens #NeuronalDamage & synaptic defects. #medsky

#STTT #OpenAccess: doi.org/10.1038/s413...

Frontiers | Serum angiotensin type-1 receptor autoantibodies and neurofilament light chain as markers of neuroaxonal damage in post-COVID patients

New from the lab‼️
Do not miss It‼️#covid #postcovid #neuronaldamage
@cimususc.bsky.social #ciberned @usc.gal #idis
👇🏻👇🏻👇🏻👇🏻👇🏻👇🏻
www.frontiersin.org/journals/imm...